Investing
Yelp Stock Analysis Q4 2023
Yelp Stocks Surge by 66% – But What’s Next?
As Yelp (NYSE: YELP) gears up to release its fiscal Q4 results on February 15, this business bellwether is fresh off a commendable trajectory. ...
The Colossal Clash: Coca-Cola Earnings and the Rise of Celsius
The eternal question of “Coke or Pepsi?” has resonated through the stock market and the hearts of consumers for generations. With both companies yielding ...
The Breakneck Pace of Record-Shattering Performances
As we course through earnings season, we are inundated daily with a flood of quarterly results. So far, the trend has been predominantly upward, ...
Howmet Aerospace Inc Quarterly Earnings Report
Howmet Aerospace Inc Exceeds Expectations with Q4 Earnings Growth
Howmet Aerospace Inc.’s (HWM) fourth-quarter 2023 financial report has sparked enthusiasm, beating expectations and showing significant growth. The aerospace giant’s adjusted earnings of 53 ...
Analysis of Coinbase Q4 Earnings
The Buzz Surrounding Coinbase (COIN) Q4 Earnings Report
Coinbase Global (COIN) is on the verge of unveiling its fourth-quarter 2023 earnings on Feb 15, following the closing bell. The company has managed ...
T. Rowe Price’s Assets Under Management Hold Steady at $1.45T in January
T. Rowe Price Group, Inc. maintained its thumb on the scale, reporting a marginal increase in its assets under management (AUM) to $1.45 trillion ...
Biogen’s Underwhelming Q4 Performance Signals Stormy Weather Ahead
Q4 Earnings: A Bumpy Road Biogen (BIIB) reported fourth-quarter 2023 adjusted earnings per share (EPS) of $2.95, distinctly missing the Zacks Consensus Estimate of ...
ResMed (RMD) Innovates With AirCurve 11 for Sleep Apnea Treatment
ResMed (RMD) Innovates With AirCurve 11 for Sleep Apnea Treatment
ResMed, Inc. RMD has unveiled its AirCurve 11 series devices, the latest bilevel devices utilizing two levels of support – inspiratory positive airway pressure ...
Gilead to Acquire CBAY: Transformational Move for GILD
Gilead to Acquire CBAY: A Striking Opportunity for GILD
Gilead Sciences, Inc. GILD has made a substantial move in its business strategy with the announcement of acquiring CymaBay Therapeutics, Inc. CBAY, for a ...
Principal Financial Group Impresses with Q4 Earnings Beat and Revenue Surge
Principal Financial Group, Inc.’s (PFG) fourth-quarter 2023 performance served as a majestic display of financial fortitude, as the company’s operating net income of $1.83 ...
